|  |
Innovative research |
| Linde Gas Therapeutics, with its unique competence and experience, has the ambition to establish itself as the preferred partner in the development of proprietary therapies arising from any intellectual property where gases, gas technology or gas competence are needed. We are co-operating with researchers in hospitals and universities in Europe and United States and we support research programs initiated by these institutions in our selected focus areas. This co-operative approach has exposed several opportunities and ideas for new product concepts. As from 2003, a new fund, the GEMI Fund, opens the door to applicants from all over the world. |
|
| |
|
|
|
|
|
| GEMI stands for Gas Enabled Medical Innovations. The GEMI Fund was founded in 2002 by Linde Gas Therapeutics in co-operation with Harvard Medical international, Boston, MA, US and the Karolinska Institute in Stockholm, Sweden. The Fund awards grants for the development of new and innovative research that addresses clinical use of gases relating to the treatment, prevention or diagnosis of diseases and other physical disorders. The grants amount to a total of 1 million dollars every other year,which makes the GEMI Fund a significant contributor to this area.
The first GEMI Fund grants were announced and celebrated at a ceremony in October 2003 in Boston, USA. Seven scientists from the USA, Germany and Portugal shared the one million dollars. The second round took place in September 2005, in Stockholm, Sweden. |
| |
|
|
|
|
|
Linde Gas Therapeutics provides the funding. Harvard Medical International in Boston, USA and the Karolinska Institutet are scientific partners and members of the GEMI Fund board together with representatives appointed by Linde Gas Therapeutics.
Harvard Medical International
Harvard Medical International (HMI) is a nonprofit, subsidiary corporation of Harvard University, USA. HMI was created in 1994 by the leadership of Harvard Medical School to respond to requests for the School's involvement in international health care initiatives. Since that time HMI has been involved in 50 projects in over 30 countries.
The Karolinska Institute
The Karolinska Institute is one of Europe's largest medical universities. It is also Sweden´s largest centre for medical training and research, accounting for 30 per cent of the medical training and 40 per cent of the medical academic research that is conducted nationwide. The Karolinska Institute handles the awarding of the Nobel Prize in Physiology or Medicine since 1895, when appointed by Alfred Nobel, with the first prize awarded in 1901.
An international board supervises and manages the GEMI Fund. It consists of members of the medical and scientific world, who have a particular interest in medical and pharmaceutical gases. Their specialties include anesthesiology, intensive care, clinical and basic physiology and pulmonology.
|
| |
|
|
|
|
|
|
